126,300
edits
Changes
Jump to navigation
Jump to search
Mercola
:Incidentally, ''Newsday'' [http://www.newsday.com/news/health/ny-hstami224479997oct22,0,4136757.story?coll=sns-ap-nationworld-headlines&track=mostemailedlink reported] October 22, 2005, that, according to drug makers, Tamiflu "will remain in short supply for as long as a year because of the drug's complicated chemistry."
:The delay is perhaps related to the controversy over property rights to the Tamiflu patent. See Dr. [[Joseph Mercola]]'s [http://www.globalresearch.ca/index.php?context=viewArticle&code=+ME20051026&articleId=1148 "Who Owns the Rights on Tamiflu: Rumsfeld To Profit From Bird Flu Hoax,"] ''Global Research'', October 26, 2005: "Since Rumsfeld holds major portions of stock in Gilead, he will handsomely profit from the scare tactics of the government that is being used to justify the purchase of $2 billion of Tamiflu."
According to its January 3, 1997, [http://www.gilead.com/wt/sec/pr_933190157 press release] announcing Rumsfeld's ascension to Chairman of the Board, Rumsfeld had been with Gilead Sciences "as a stalwart board member since the company's earliest days" in 1988.
